Alpha Teknova, Inc.
NASDAQ:TKNODrug Manufacturers - Specialty & Generic
+$0.23 today
- Market cap
- $495.68M
- Beta
- 0.63
- P/E (TTM)
- -16.2
- EPS (TTM)
- -$0.32
Volume 0.30M
Average 0.13M
TKNO EBITDA Margin
EBITDA as a percentage of revenue.
Alpha Teknova, Inc.NASDAQ: TKNO
EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026
EBITDA Margin widens to -24.5%
EBITDA Margin was -24.5% in Q1 FY2026, up 5.1 pp from a year earlier. On a trailing-twelve-month basis it was -23.8%, up 18.3 pp year over year. Over 3 fiscal years it widened by 37.0 pp.
Context
- EBITDA Margin widened in 2 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 6 analysts of -12.5% for the fiscal year ending Dec 2026, up from -25.0% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -24.5%+5.8 pp QoQ
- Last fiscal yearDec 2025
- -25.0%+26.8 pp YoY
- LTMMar 2026
- -23.8%+18.3 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +5.1 pp | -7.0 pp | -12.1 pp |
| 1 year | +26.8 pp | +12.6 pp | -14.2 pp |
| 3 years | +37.0 pp | +29.1 pp | -7.9 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -25.0%
- Year-over-year change
- +26.8pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -25.0% | +26.8pp |
| FY2024 | 2024-12-31 | -51.8% | +17.8pp |
| FY2023 | 2023-12-31 | -69.6% | -7.6pp |
| FY2022 | 2022-12-31 | -62.0% | -37.2pp |
| FY2021 | 2021-12-31 | -24.8% | — |
EBITDA Margin vs competitors
How TKNO compares with its peers on the latest reported figures
- TKNO's LTM Mar 2026 EBITDA Margin of -23.8% is the 6th highest of the 8 companies compared; the peer median is -7.5%.
- Its year-over-year change of +18.3 pp is the 2nd highest of 8, against a peer median of +0.1 pp.
- Over three fiscal years its change of +37.0 pp compares with a peer median of -9.9 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Sep 2026 | 26.8% | +8.6 pp | -11.9 pp | |
| LTM Jun 2026 | 22.3% | +5.6 pp | -9.9 pp | |
| LTM Mar 2026 | 17.4% | +0.1 pp | -3.0 pp | |
| LTM Mar 2026 | -7.5% | -19.9 pp | +166.6 pp | |
| LTM Sep 2026 | -15.2% | -24.8 pp | -32.6 pp | |
| LTM Mar 2026 | -23.8% | +18.3 pp | +37.0 pp | |
| LTM Jun 2026 | -26.6% | +89.9 pp | -148.5 pp | |
| LTM Mar 2026 | -94.5% | -30.2 pp | +72.1 pp | |
| Peer median (excluding TKNO) | -7.5% | +0.1 pp | -9.9 pp | |
Competitors are the stored peer set for TKNO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 36.89M | 41.42M | 36.68M | 37.75M | 40.52M |
| Cost of Revenue | 19.27M | 23.94M | 26.39M | 30.51M | 27.08M |
| Gross Profit | 17.62M | 17.48M | 10.3M | 7.23M | 13.44M |
| Gross Margin | 47.8% | 42.2% | 28.1% | 19.2% | 33.2% |
| Research & Development | 4.31M | 7.74M | 5.57M | 2.76M | 2.2M |
| Selling, General & Admin | 24.17M | 37.45M | 34.78M | 29.47M | 27.07M |
| Operating Expenses | 29.63M | 67.14M | 45.86M | 33.38M | 30.42M |
| Depreciation & Amortization | 2.88M | 3.17M | 5.66M | 6.58M | 6.34M |
| EBITDA | (9.17M) | (25.69M) | (25.54M) | (19.57M) | (10.15M) |
| EBITDA Margin | -24.8% | -62.0% | -69.6% | -51.8% | -25.0% |
| Operating Income | (12.01M) | (49.66M) | (35.56M) | (26.15M) | (16.98M) |
| Operating Margin | -32.5% | -119.9% | -96.9% | -69.3% | -41.9% |
| Interest Income | 0 | 213K | 0 | 0 | 0 |
| Interest Expense | 589K | 0 | 833K | 687K | 710K |
| Other Income / Expenses | (629K) | 268K | (1.52M) | (687K) | (225K) |
| Income Before Tax | (12.64M) | (49.39M) | (37.08M) | (26.83M) | (17.2M) |
| Pre-Tax Margin | -34.3% | -119.2% | -101.1% | -71.1% | -42.5% |
| Income Tax Expense | (2.83M) | (1.92M) | (298K) | (88K) | 58K |
| Net Income | (9.8M) | (47.47M) | (36.78M) | (26.75M) | (17.26M) |
| Net Margin | -26.6% | -114.6% | -100.3% | -70.9% | -42.6% |
| EPS (Basic) | (0.35) | (1.69) | (1.16) | (0.57) | (0.32) |
| EPS (Diluted) | (0.35) | (1.69) | (1.16) | (0.57) | (0.32) |
| Weighted Avg Shares | 28.01M | 28.08M | 31.82M | 46.75M | 53.48M |
| Weighted Avg Shares (Diluted) | 28.01M | 28.08M | 31.82M | 46.75M | 53.48M |
Alpha Teknova, Inc.
NASDAQ:TKNO
Intrinsic Alpha fair value
Locked
Current Price
$7.88
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.